Determinants of the Interaction of the Spinal Muscular Atrophy Disease Protein SMN with the Dimethylarginine-modified Box H/ACA Small Nucleolar Ribonucleoprotein GAR1
Open Access
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (50) , 48087-48093
- https://doi.org/10.1074/jbc.m204551200
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Coilin forms the bridge between Cajal bodies and SMN, the Spinal Muscular Atrophy proteinGenes & Development, 2001
- Macromolecular complexes: SMN — the master assemblerCurrent Biology, 2001
- PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in ProteinsJournal of Biological Chemistry, 2001
- State of the ArgCell, 2001
- Cajal Bodies: The First 100 YearsAnnual Review of Cell and Developmental Biology, 2000
- Mutational Analysis of Fibrillarin and Its Mobility in Living Human CellsThe Journal of cell biology, 2000
- The Spinal Muscular Atrophy Disease Gene Product, SmnThe Journal of cell biology, 1999
- RNase Treatment of Yeast and Mammalian Cell Extracts Affects in Vitro Substrate Methylation by Type I Protein Arginine N-MethyltransferasesBiochemical and Biophysical Research Communications, 1999
- SMN oligomerization defect correlates with spinal muscular atrophy severityNature Genetics, 1998
- The nucleolar protein, B-36, contains a glycine and dimethylarginine-rich sequence conserved in several other nuclear RNA-binding proteinsBiochemical and Biophysical Research Communications, 1988